- Home
- VNDA vs GAMB Comparison
VNDA vs GAMB Comparison
Compare VNDA & GAMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- GAMB
- Stock Information
- Founded
- VNDA 2002
- GAMB 2006
- Country
- VNDA United States
- GAMB Jersey
- Employees
- VNDA N/A
- GAMB N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- GAMB Services-Misc. Amusement & Recreation
- Sector
- VNDA Health Care
- GAMB Consumer Discretionary
- Exchange
- VNDA Nasdaq
- GAMB Nasdaq
- Market Cap
- VNDA 249.4M
- GAMB 273.9M
- IPO Year
- VNDA 2006
- GAMB 2021
- Fundamental
- Price
- VNDA $4.41
- GAMB $6.69
- Analyst Decision
- VNDA Strong Buy
- GAMB Strong Buy
- Analyst Count
- VNDA 3
- GAMB 8
- Target Price
- VNDA $14.00
- GAMB $15.13
- AVG Volume (30 Days)
- VNDA 682.0K
- GAMB 699.0K
- Earning Date
- VNDA 10-29-2025
- GAMB 11-13-2025
- Dividend Yield
- VNDA N/A
- GAMB N/A
- EPS Growth
- VNDA N/A
- GAMB N/A
- EPS
- VNDA N/A
- GAMB 0.40
- Revenue
- VNDA $212,074,000.00
- GAMB $147,655,000.00
- Revenue This Year
- VNDA $14.32
- GAMB $38.41
- Revenue Next Year
- VNDA $37.05
- GAMB $11.58
- P/E Ratio
- VNDA N/A
- GAMB $16.86
- Revenue Growth
- VNDA 11.12
- GAMB 27.57
- 52 Week Low
- VNDA $3.81
- GAMB $6.66
- 52 Week High
- VNDA $5.70
- GAMB $17.14
- Technical
- Relative Strength Index (RSI)
- VNDA 34.91
- GAMB 28.53
- Support Level
- VNDA $4.32
- GAMB $7.55
- Resistance Level
- VNDA $4.51
- GAMB $7.84
- Average True Range (ATR)
- VNDA 0.23
- GAMB 0.23
- MACD
- VNDA -0.13
- GAMB -0.04
- Stochastic Oscillator
- VNDA 9.44
- GAMB 0.42
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About GAMB Gambling.com Group Limited
Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casinos online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.